UPDATE on Electronic Prescribing Requirement 

The Bureau of Professional Licensing’s (BPL) enforcement of the electronic prescribing standard will coincide with the Centers for Medicare & Medicaid Services' (CMS) enforcement schedule for Part D prescription drug programs. " BPL will initiate enforcement of Michigan’s new electronic prescribing standard on the same date that CMS begins its electronic prescribing enforcement schedule. At this time, the CMS requirement will be enforced starting January 1, 2023,"

Electronic Prescribing FAQ

The CME sessions for 2021 Autumn Scientific Convention available on demand

Did you register for in person?
If you have registered for the 2021 Autumn Scientific Convention that was scheduled for Grand Rapids,
please note that the MOA Autumn in person convention at the Amway Grand Plaza this weekend October 29-31 was cancelled. Your registration was automatically transferred to the MOA Autumn On Demand program and you should have received an email with access information to the MOA Learning Center on the CE21 platform.

Are you pre-registered for On Demand?
If you pre-registered for the Autumn On Demand sessions you should have received an email with access information to the MOA Learning Center on the CE21 platform. 

Looking to register for On Demand 2021 Autumn sessions?
Visit the MOA Learning Center at moa.ce21.com for access to 2021 Autumn sessions, plus other CME offerings. 

2021 Autumn CME Sessions

23 AOA Category 1-A Credits - 23 AMA PRA Category 1 Credit(s)TM

Sleep Apnea • Gastroenterology • Palliative Care Training • Hypertension in Geriatrics • Driver’s Rehabilitation
Cardiology Update • Child/Adolescent Psychiatrist Addressing Pandemic • Basic Management of Parkinson’s Disease 
Lifestyle & Functional Medicine • Osteopathic Manipulative Medicine • Women’s Health • Safe Opioid Seminar (meets MI LARA requirement)

If you have any question, please contact Melissa Budd: [email protected]

MOA Learning Center

Spring CME Sessions On Demand

The Spring CME sessions are available On Demand.
Visit the MOA Learning Center to register and view other On Demand programs. 

2021 Spring CME Program
MOA Learning Center




The CDC (Centers for Disease Control and Prevention) has updated the Interim Clinical Considerations as of December 23, 2021.  We are sending you a summary of those updates.

Updated information about a second formulation of Pfizer-BioNTech Covid-19 Vaccine that is authorized for use in persons age 12 years and older.

There are two formulations of Pfizer-BioNTech that are FDA-approved for use in persons aged 16 years and older and FDA-authorized for use in persons aged 12 through 15 years:

  • A formulation supplied in a multiple dose vial with a purple cap and label with a purple border, and which must be diluted prior to use. It uses phosphate buffered saline (PBS). Each diluted 0.3 mL dose contains 30 µg of modified mRNA.
  • A formulation supplied in a multiple dose vial with a gray cap and label with a gray border, and which that does not require dilution prior to use. It uses tromethamine (Tris) buffer. Each 0.3 mL dose contains 30 µg of modified mRNA.  Be sure to note the difference in storage and handling and preparation with this formulation.

Updated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-19 outbreaks.

  • COVID-19 vaccines are not recommended for post-exposure prophylaxis to prevent SARS-CoV-2 infection, however:
    • to avoid missed opportunities for vaccination, vaccination during quarantine could be considered during outreach and contact tracing activities or at the time of post-exposure SARS-CoV-2 testing in certain circumstances. Examples might include when people:

1) are likely to have repeated SARS-CoV-2 exposures because they are unable to effectively quarantine (e.g., residing in a congregate or crowded setting or during outbreaks in their community), or,

2) will have limited access to vaccination after their quarantine period has ended, or,

3) are unlikely to otherwise seek vaccination after their quarantine period has ended.

    • In such situations, the person recommended for quarantine can receive vaccination as long as:

1) they do not have symptoms consistent with COVID-19, and,

2) appropriate infection prevention and control procedures are employed during vaccination. Furthermore, unvaccinated people who are being tested for SARS-CoV-2 may be candidates for same-day vaccination if they do not have symptoms consistent with COVID-19.

People should be counseled that COVID-19 vaccines are effective, especially at preventing serious COVID-19 illnesses. However, they should also be informed that vaccination may not prevent SARS-CoV-2 infection until 2 weeks after the primary series is completed, i.e., will not prevent them from getting COVID-19 from the current exposure but should help protect them from infection after future exposures. In addition, SARS-CoV-2 viral testing may be necessary to differentiate between common post-vaccination symptoms and symptoms of SARS-CoV-2 infection:

  • Persons who develop signs and symptoms not associated with the COVID-19 vaccination (e.g., cough, shortness of breath, runny nose, sore throat, loss of taste or smell) should isolate and be evaluated for SARS-CoV-2 infection as soon as possible.
  • Persons who develop signs and symptoms that could be from either COVID-19 vaccination or SARS-CoV-2 infection (e.g., fever, fatigue, headache, myalgia) without typical COVID-19 symptoms described above, and are clinically stable, should isolate and, if symptoms do not improve by two days post-vaccination, be evaluated for SARS-CoV-2 infection.

Update to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some people after COVID-19 vaccines.

Thank you,

MDHHS Division of Immunization

Stay up-to-date with the latest information about COVID-19 vaccines at Michigan.gov/COVIDVaccine.

Please direct Coronavirus (COVID-19) related inquiries to the DHHS COVID-19 hotline at 1-888-535-6136.  For the most up-to-date information, facts and FAQs, go to www.michigan.gov/Coronavirus

Prior Authorization and Senate Bill 612

The legislature concluded work on the Fiscal Year 2020-21 budget and  made good use of the few joint session days before adjourning until after the November 3rd Election.  It was a pleasant development that Senator VanderWall pushed action on his legislative proposal dealing with prior authorization (SB 612). As the primary sponsor of the bill and chairing the Senate Health Policy and Human Services Committee, Sen VanderWall succeeded in reporting out the measure despite strong opposition from insurers and purchasers. The committee vote was 8 -0 with 2 passes.  While much work needs to continue on the bill and negotiations will continue while the bill remains pending on the Senate floor,  the Michigan Osteopathic Association extends a  thank you to the Senate Health Policy and Human Services Committee and Chairperson Curt Vanderwall for advancing this bill that holds promise for ending dangerous delays in treating patients and removing step therapy obstacles physicians are subject to by insurance companies. When it comes to health care, Michigan patients deserve reforms that removes red tape and puts treatment in the hands of physicians and their patients. The issue of Prior Authorization has earned bi-partisan support and we salute the legislators who have moved Senate Bill 612 forward in the legislative process.

Take Action - Let your Senator know Prior Authorization needs reform

COVID-19 Practice Certification Assessment

It is recommended that participants read the PHYSICIAN PRACTICE COVID-19 PLAYBOOK and watch the video before taking this practice assessment.
Upon achieving a passing grade with this practice-assessment, participants will be able to print their own Certificate of Completion for display in your practice.

Please Note:
This assessment Will NOT allow you to save and finish at a later date
This assessment Will NOT allow you to go back and change your answers
You must attain of a passing mark at least 88% on this assessment to generate your own Certificate of Completion for your records

Practice Assessment Link

Only 2 assessments can be taken on the same device over a 24 hour period. As long as participants are on their own computer or device, it will not be an issue

Video recording of the Developing a Plan to Re-Open Your Practice webinar (link to YouTube video)  

The Michigan Osteopathic Association (MOA) continues to monitor the ongoing spread of the Coronavirus disease 2019 (COVID-19). While the immediate risk of exposure for the residents of Michigan remains relatively low, the MOA encourages all residents to follow recommendations to limit the spread of the COVID-19 virus. The MOA conducts daily meetings to study updates to the situation in Michigan and stay informed on how other states are responding to the outbreak of COVID-19. In an effort to provide accurate information on the various issues surrounding the COVID-19 outbreak to MOA members, we have created a webpage to aggregate information: 

MOA COVID-19 Information & Resources

MDHHS Coronavirus General Information (8am-5pm daily): 888-535-6136
MDHHS COVID-19 Emergency Laboratory Network Hotline 888-277-9894 

Centers for Disease Control: 800-232-4636





Multiview advertisement


ACEMAPP connects employers with professionals with job opportunities in the Great Lakes region. Employers include private practices, hospitals, health systems, community health centers, federally qualified health clinics, specialty practices, prison health, and telemedicine providers. Available locations range from rural to urban areas, and many opportunities qualify for loan repayment.
Search Jobs
Post Jobs

Opioid Prescribers' Legislative Alert

On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. The MOA is part of a coalition that is working with the Department of Health and Human Services (MDHHS) to provide input from healthcare professionals in regards to the laws, regulations and systems used by prescribers. 

For MOA members, a page has been created with an overview, a link to a summary (PDF) and a link to a survey designed to get feedback from the MOA membership.

Opioid Alert page (MOA login page)
Michigan Automated Prescription System (MAPS) - User Support Manual